{"id":"a484c57e-7b94-5cbb-bd72-88f5bb613226","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-telomere-lengthening","predicate":"increases","statement":"Telomere length of T helper, T cytotoxic, natural killer and B cells increased by over 20% after 60 sessions, with B cells rising 37.63% after the course.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"b443296b-8fa3-5d23-95ae-7bb648610bee","mechanism_event_label":"A marker of cell ageing moved in the opposite direction to ageing.","subject":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"object":{"id":"68afdc8d-2bc0-5056-8f74-84ed9af3939e","slug":"telomere-length","display_name":"Telomere length in peripheral blood mononuclear cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"b443296b-8fa3-5d23-95ae-7bb648610bee","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-telomere-lengthening-event","event_type":"observed_intervention","label":"A marker of cell ageing moved in the opposite direction to ageing.","description":"Telomere length of T helper, T cytotoxic, natural killer and B cells increased by over 20% after 60 sessions, with B cells rising 37.63% after the course.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"d0db4e40-af3f-5826-b885-27ea06cc710e","slug":"t-helper-cells","display_name":"T helper cells","entity_type_key":"cell_type"},"role":"measured_cell","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"c7043877-22ca-565e-bcf3-07a2a6be1ec4","slug":"b-cells","display_name":"B lymphocytes","entity_type_key":"cell_type"},"role":"measured_cell","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"f2a75588-8d8b-5b44-9cf8-921687fea0ad","slug":"natural-killer-cells","display_name":"Natural killer cells","entity_type_key":"cell_type"},"role":"measured_cell","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"68afdc8d-2bc0-5056-8f74-84ed9af3939e","slug":"telomere-length","display_name":"Telomere length in peripheral blood mononuclear cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/hbot-research/33206062.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"3ac16eb39be25c350e6a42fff6ee8cbf22159514a750bc3c7bafcbf734f03ecf\", \"start_char\": 0, \"end_char\": 1622, \"text_sha256\": \"3ac16eb39be25c350e6a42fff6ee8cbf22159514a750bc3c7bafcbf734f03ecf\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Prospective trial of 35 healthy independently living adults aged 64 and over","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Sixty daily hyperbaric oxygen exposures, sampled at baseline, 30 and 60 sessions and after the course","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A single-arm prospective trial without a control group, in a normal ageing population. Telomere length and senescent-cell percentage are cell measurements, not health outcomes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A marker of cell ageing moved in the opposite direction to ageing.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[hbot-p33206062] Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. (2020). https://pubmed.ncbi.nlm.nih.gov/33206062/ DOI: 10.18632/aging.202188","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Peripheral blood mononuclear cells","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"f7724d82-2c70-55a7-9341-01fd8cd813eb","evidence_kind":"source_excerpt","locator":"Lines 1115-1126","start_line":1115,"end_line":1126,"excerpt":"### hbot-telomere-lengthening\nTelomere length of T helper, T cytotoxic, natural killer and B cells increased by over 20% after 60 sessions, with B cells rising 37.63% after the course.\nCondition category: normal\nnutrient_topic: Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.\nplain_language: A marker of cell ageing moved in the opposite direction to ageing.\norganism: Human\ntissue_or_cell_type: Peripheral blood mononuclear cells\nexperimental_model: Prospective trial of 35 healthy independently living adults aged 64 and over\nlimitations: A single-arm prospective trial without a control group, in a normal ageing population. Telomere length and senescent-cell percentage are cell measurements, not health outcomes.\nexposure: Sixty daily hyperbaric oxygen exposures, sampled at baseline, 30 and 60 sessions and after the course\nevidence_span: {\"source_cache\": \"artifacts/hbot-research/33206062.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"3ac16eb39be25c350e6a42fff6ee8cbf22159514a750bc3c7bafcbf734f03ecf\", \"start_char\": 0, \"end_char\": 1622, \"text_sha256\": \"3ac16eb39be25c350e6a42fff6ee8cbf22159514a750bc3c7bafcbf734f03ecf\"}\n[hbot-p33206062] Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. (2020). https://pubmed.ncbi.nlm.nih.gov/33206062/ DOI: 10.18632/aging.202188","model_system":"Prospective trial of 35 healthy independently living adults aged 64 and over","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [hbot-p33206062] Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. (2020). https://pubmed.ncbi.nlm.nih.gov/33206062/ DOI: 10.18632/aging.202188","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dbf39b48-c95e-5291-b404-349ffbc4488f","stable_key":"import-488ea171-36b8-5ef6-b5d3-98563980fdbf","title":"Hyperbaric oxygen: the exposure, its reactive species, the signals they carry, and the nutrient-dependent enzymes that handle them (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"fb2443321804010d82c6b96ab61cc51b4b6628ddbb15751cb0e90b491606e79c","revision_id":"bb699ea5-b492-5728-b22c-48f0842a8ac9","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}